$91.04
0.04%
NYSE, Nov 28, 10:00 pm CET
ISIN
US3795772082
Symbol
GMED

Globus Medical, Inc. Class A Stock price

$91.04
+28.29 45.08% 1M
+31.83 53.76% 6M
+8.33 10.07% YTD
+5.75 6.74% 1Y
+20.01 28.17% 3Y
+30.96 51.53% 5Y
+63.91 235.57% 10Y
+77.54 574.37% 20Y
NYSE, Closing price Fri, Nov 28 2025
-0.04 0.04%

New AI Insights on Globus Medical, Inc. Class A Insights AI Insights on Globus Medical, Inc. Class A

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$12.3b
Enterprise Value
$11.9b
Net debt
positive
Cash
$390.5m
Shares outstanding
134.6m
Valuation (TTM | estimate)
P/E
29.2 | 27.9
P/S
4.4 | 4.2
EV/Sales
4.3 | 4.1
EV/FCF
20.8
P/B
2.8
Financial Health
Equity Ratio
79.5%
Return on Equity
2.5%
ROCE
10.4%
ROIC
9.7%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$2.8b | $2.9b
EBITDA
$599.9m | $824.2m
EBIT
$481.1m | $563.1m
Net Income
$423.8m | $440.1m
Free Cash Flow
$569.9m
Growth (TTM | estimate)
Revenue
11.8% | 15.6%
EBITDA
72.5% | 138.9%
EBIT
109.0% | 149.6%
Net Income
363.1% | 327.3%
Free Cash Flow
94.0%
Margin (TTM | estimate)
Gross
67.1%
EBITDA
21.7% | 28.3%
EBIT
17.4%
Net
15.3% | 15.1%
Free Cash Flow
20.6%
More
EPS
$3.1
FCF per Share
$4.2
Short interest
4.9%
Employees
5k
Rev per Employee
$480.0k
Show more

Is Globus Medical, Inc. Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Globus Medical, Inc. Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Globus Medical, Inc. Class A forecast:

13x Buy
62%
8x Hold
38%

Analyst Opinions

21 Analysts have issued a Globus Medical, Inc. Class A forecast:

Buy
62%
Hold
38%

Financial data from Globus Medical, Inc. Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
2,770 2,770
12% 12%
100%
- Direct Costs 913 913
7% 7%
33%
1,857 1,857
24% 24%
67%
- Selling and Administrative Expenses 1,113 1,113
15% 15%
40%
- Research and Development Expense 144 144
21% 21%
5%
600 600
73% 73%
22%
- Depreciation and Amortization 119 119
1% 1%
4%
EBIT (Operating Income) EBIT 481 481
109% 109%
17%
Net Profit 424 424
363% 363%
15%

In millions USD.

Don't miss a Thing! We will send you all news about Globus Medical, Inc. Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Globus Medical, Inc. Class A Stock News

Positive
Investors Business Daily
6 days ago
This medical products stock breaks out of a cup-with-handle base and is in a buy zone. The company makes technology used for spine surgery.
Positive
Investors Business Daily
16 days ago
Globus Medical's spine business is a big earnings driver, propelling its stock closer to a buy point.
Positive
Seeking Alpha
19 days ago
Globus Medical has rebounded strongly, driven by accelerating earnings and successful integration of acquisitions like NuVasive and Nevro. The company delivered on robust Q3 results, with 7% organic growth and a significant hike in full-year adjusted earnings guidance to $3.80 per share. Despite a 35% share price surge, shares trades at a reasonable 21x earnings, supported by a strong balance s...
More Globus Medical, Inc. Class A News

Company Profile

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

Head office United States
CEO Daniel Scavilla
Employees 5,300
Founded 2003
Website www.globusmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today